Stephen Wargacki

Insider Reports History

Entity
Individual
Location
C/O Aquestive Therapeutics, Inc., 30 Technology Drive, Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Wargacki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Science Officer Common Stock 268K $1.31M $4.88 May 10, 2024 Direct
Aquestive Therapeutics, Inc. Chief Science Officer Performance Stock Units 67.5K Aug 9, 2023 Direct
Aquestive Therapeutics, Inc. Chief Science Officer Non-Qualified Stock Option (right to buy) 56.3K Mar 7, 2024 Direct

Insider Reports Filed by Stephen Wargacki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. May 10, 2024 1 $0 4 May 13, 2024 Chief Science Officer
AQST Aquestive Therapeutics, Inc. Mar 9, 2024 1 -$95.2K 4/A Oct 2, 2024 Chief Science Officer
AQST Aquestive Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 SVP, Research & Development
AQST Aquestive Therapeutics, Inc. May 5, 2023 1 $0 4 May 5, 2023 SVP, Research & Development
AQST Aquestive Therapeutics, Inc. Mar 10, 2023 3 -$1.57K 4 Mar 11, 2024 SVP, Research & Development
AQST Aquestive Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 9, 2023 SVP, Research & Development
AQST Aquestive Therapeutics, Inc. Jan 1, 2023 0 $0 3 Jan 11, 2023 SVP, Research & Development